MICHELLE MCCALL: Open Payments
NPI 1144708827 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 52 payments from 19 companies in 2025. Trend: 2023 $708 · 2024 $2,322 · 2025 $1,335
Food & beverage: $1,335
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $200 |
| IMMUNITYBIO, INC. | 5 | $158 |
| Medtronic, Inc. | 2 | $148 |
| Ferring Pharmaceuticals Inc. | 5 | $130 |
| Antares Pharma, Inc. | 5 | $98 |
| Boston Scientific Corporation | 4 | $96 |
| Janssen Biotech, Inc. | 2 | $89 |
| ConvaTec Inc. | 2 | $87 |
| UROGEN PHARMA, INC. | 2 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
Products named: ANKTIVA, ADSTILADRIN, INTERSTIM, ORGOVYX, XYOSTED, GEMTESA, GENTLECATH GLIDE, Axonics.
Industry payments across TX — which companies pay providers there.
